The Freudenberg Group is a family company offering its customers technically challenging product solutions and services. The Group develops and manufactures seals, vibration control components, filters, nonwovens, products for surface treatment, release agents and specialty lubricants, medical and mechatronic products. Milestones of the Group's innovations are the Simmering, Vileda wipes and Evolon microfilaments. Freudenberg's revolutionary new Simmerring ushered the company into a new era in sealing technology. The Simmerring - named after its inventor, Walther Simmer - was a radial shaft seal which replaced the felt seals that had been previously used. The production of Vlieseline interlinings and Vileda cloths, both nonwoven products, started in the 1950s. With Evolon technology, Freudenberg developed an entirely new spunbonded microfilament nonwoven production process which set new standards.
Freudenberg nonwovens are used in a multitude of applications thanks to their inexhaustible material properties and functionalities. We are constantly developing new products in partnership with our customers: From automatic print head cleaning for copying machines, surface protection in industrial packaging, artificial turf and tent coatings to shoe insoles. The strengths of Freudenberg Nonwovens are the ability to offer tailor-made solutions to customers, the long-standing experience of a global R&D team and the know-how for different nonwoven technologies. And: We constantly review our processes and structures to remain competitive on a global level. Freudenberg Nonwovens is part of the Freudenberg Group's R&D network. Via Freudenberg's central R&D department we have access to R&D experts covering all disciplines in material science. At the same time this corporate R&D team offers technologies and analytical equipment which a standalone Nonwovens business group cannot afford.
The market for medical devices is steadily growing. The growth rates of segments like Traditional Wound Care, Advanced Wound Care and Stoma have been showing moderate but also very stable growth rates over the years. The business with Transdermal Delivery Systems is growing strongly as the benefits of this technology, which originated in Japan, are spreading to the US and Europe. However budget cuts and general cost pressures in the European healthcare sector are challenging the industry to come up with cost effective solutions. Customers in emerging countries ask for cost effective solutions which provide good performance. The US and Europe request higher performance. There is also a trend towards more effective product solutions for complex indications (e.g. chronic wounds) which help to reduce the total cost of treatment. We are also seeing an increasing trend towards self-treatment products. Advanced Wound Care and Transdermal Delivery Systems are the fastest growing end use applications.
DISCLAIMER: All views and opinions expressed in this column are solely of the interviewee, and they do not reflect in any way the opinion of technicaltextile.net.